Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy of MabThera in patients with rheumatoid arthritis, by measurement of disease parameters through magnetic resonance of the hand (RESONAR Study).

Next Previous
Trial Profile

Efficacy of MabThera in patients with rheumatoid arthritis, by measurement of disease parameters through magnetic resonance of the hand (RESONAR Study).

Status: Discontinued
Phase of Trial: Phase IV

Latest Information Update: 08 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Rituximab (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Acronyms RESONAR
  • Sponsors Roche

Most Recent Events

  • 27 Mar 2014 According to ClinicalTrials.gov record, status changed from completed to discontinued.
  • 19 Nov 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
  • 16 Jul 2010 Status changed from not yet recruiting to recruiting as reported by Roche record.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top